Physician profile
Brandy E Bartholomew
NPI 1063802346
$7,360.09
in general payments reported to CMS, 2019-2025
36 companies · $1,608 in 2025
The $1,608 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $580 · 2022: $1,214 · 2023: $1,863 · 2024: $2,094 · 2025: $1,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,565.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,205.10 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $655.89 | 2021-2025 | Ultomiris, Soliris |
| Ucb, INC. | $584.05 | 2023-2025 | Nayzilam, Rystiggo, Zilbrysq |
| Abbvie INC. | $533.58 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $506.85 | 2021-2025 | Rytary, Crexont, Ongentys |
| Argenx US, INC. | $458.99 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $402.93 | 2023-2025 | Vumerity, Skyclarys, Tysabri |
| Sk Life Science, INC. | $374.41 | 2022-2025 | |
| Eisai INC. | $310.14 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $286.49 | 2021-2025 | Nuplazid |
| Lundbeck LLC | $281.02 | 2021-2025 | Vyepti |
| Neurocrine Biosciences, INC. | $209.38 | 2023-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $207.88 | 2023-2025 | Zeposia |
| Genentech USA, INC. | $170.51 | 2022-2024 | Ocrevus, Enspryng |
| Otsuka America Pharmaceutical, INC. | $150.72 | 2023-2025 | Rexulti, Nuedexta |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $142.79 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Astrazeneca Pharmaceuticals Lp | $133.38 | 2021-2024 | Andexxa |
| Biohaven Pharmaceutical Holding Company Ltd. | $129.57 | 2022 | |
| Sunovion Pharmaceuticals INC. | $84.26 | 2021 | |
| Tg Therapeutics, INC. | $68.14 | 2025 | |
| Pfizer INC. | $61.61 | 2023-2025 | |
| Lilly USA, LLC | $48.36 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $38.24 | 2021 | |
| Neurelis, INC. | $36.61 | 2025 | Valtoco |
| Janssen Pharmaceuticals, INC | $34.40 | 2021 | |
| Nevro Corp. | $33.83 | 2023 | Senza |
| Alnylam Pharmaceuticals INC. | $25.45 | 2022 | |
| Amgen INC. | $25.40 | 2021-2022 | |
| Axsome Therapeutics, INC. | $25.27 | 2025 | Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $24.71 | 2023 | |
| Csl Behring | $23.72 | 2025 | Hizentra |
| Emd Serono, INC. | $19.75 | 2023 | Mavenclad |
| Avion Pharmaceuticals | $19.43 | 2022 | |
| Harmony Biosciences LLC | $18.72 | 2025 | |
| Tanabe Pharma America, INC. | $14.60 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Bartholomew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.